Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Aug 2026 for BridgeBio Pharma, Inc., €2.1M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kumar Haldea Family Irrevocable Tru/t/a Dtd 05/18/2019: trading record in brief
Our data holds just one disclosure by Kumar Haldea Family Irrevocable Tru/t/a Dtd 05/18/2019, dated 19 August 2026, reporting a transaction worth €2.1M in BridgeBio Pharma, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kumar Haldea Family Irrevocable Tru/t/a Dtd 05/18/2019
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 30,000 shares@ US$82.98CommonSEC144:0001950047-26-008424
1 of 1 declaration
